APO Research

APO RESEARCH · REPORT

Automated and Rapid Microbiological Tests Bussiness

Selected research

Market Outlook & Growth Opportunities

Global Automated and Rapid Microbiological Tests Bussiness Market Outlook and Growth Opportunities 2026

Market perspective

The global Automated and Rapid Microbiological Tests Bussiness market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Automated and Rapid Microbiological Tests Bussiness market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Automated and Rapid Microbiological Tests Bussiness market include Thermo Fisher Scientific, Roche, Siemens Healthcare Diagnostics, Sekisui Diagnostics, Remel, Quidel Corporation, Oxoid Limited, Orion Diagnostica Oy and Orasure Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Automated and Rapid Microbiological Tests Bussiness market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Automated and Rapid Microbiological Tests Bussiness and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Automated and Rapid Microbiological Tests Bussiness revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Automated and Rapid Microbiological Tests Bussiness market.

Automated and Rapid Microbiological Tests Bussiness Segment by Company

Thermo Fisher Scientific

Roche

Siemens Healthcare Diagnostics

Sekisui Diagnostics

Remel

Quidel Corporation

Oxoid Limited

Orion Diagnostica Oy

Orasure Technologies

Meridian Biosciences

MedMira

Gen-Probe

Celsis International

Cellabs

Bio-Rad Laboratories

BioMerieux SA

Becton Dickinson and Company

Abbott Laboratories

Automated and Rapid Microbiological Tests Bussiness Segment by Type

Automated Identification & Susceptibility Systems

Automated Tuberculosis Systems

Automated Blood Culture Systems

Streptococcal Infection Rapid Tests

GC/Chlamydia Rapid Tests

Other

Automated and Rapid Microbiological Tests Bussiness Segment by Application

Clinical

Non-Clinical

Automated and Rapid Microbiological Tests Bussiness Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Automated and Rapid Microbiological Tests Bussiness status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Automated and Rapid Microbiological Tests Bussiness key companies, revenue, market share, and recent developments.

3. To split the Automated and Rapid Microbiological Tests Bussiness breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Automated and Rapid Microbiological Tests Bussiness market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Automated and Rapid Microbiological Tests Bussiness significant trends, drivers, influence factors in global and regions.

6. To analyze Automated and Rapid Microbiological Tests Bussiness competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated and Rapid Microbiological Tests Bussiness market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automated and Rapid Microbiological Tests Bussiness and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated and Rapid Microbiological Tests Bussiness.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automated and Rapid Microbiological Tests Bussiness industry.

Chapter 3: Detailed analysis of Automated and Rapid Microbiological Tests Bussiness company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Automated and Rapid Microbiological Tests Bussiness in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Automated and Rapid Microbiological Tests Bussiness in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Automated and Rapid Microbiological Tests Bussiness Industry Trends Table 2. Automated and Rapid Microbiological Tests Bussiness Industry Drivers Table 3. Automated and Rapid Microbiological Tests Bussiness Industry Opportunities and Challenges Table 4. Automated and Rapid Microbiological Tests Bussiness Industry Restraints Table 5. Global Automated and Rapid Microbiological Tests Bussiness Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Automated and Rapid Microbiological Tests Bussiness Revenue Share by Company (2021-2026) Table 7. Global Automated and Rapid Microbiological Tests Bussiness Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Automated and Rapid Microbiological Tests Bussiness Key Company Manufacturing Base & Headquarters Table 9. Global Automated and Rapid Microbiological Tests Bussiness Company, Product Type & Application Table 10. Global Automated and Rapid Microbiological Tests Bussiness Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Automated and Rapid Microbiological Tests Bussiness by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Automated Identification & Susceptibility Systems Table 15. Significant Companies of Automated Tuberculosis Systems Table 16. Significant Companies of Automated Blood Culture Systems Table 17. Significant Companies of Streptococcal Infection Rapid Tests Table 18. Significant Companies of GC/Chlamydia Rapid Tests Table 19. Significant Companies of Other Table 20. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type (2021-2026) Table 24. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Clinical Table 26. Significant Companies of Non-Clinical Table 27. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application (2021-2026) Table 31. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application (2027-2032) Table 32. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Region (2021-2026) Table 35. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Region (2027-2032) Table 37. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Market Share by Country (2021-2026) Table 40. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Market Share by Country (2027-2032) Table 42. Thermo Fisher Scientific Company Information Table 43. Thermo Fisher Scientific Business Overview Table 44. Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 46. Thermo Fisher Scientific Recent Development Table 47. Roche Company Information Table 48. Roche Business Overview Table 49. Roche Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Roche Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 51. Roche Recent Development Table 52. Siemens Healthcare Diagnostics Company Information Table 53. Siemens Healthcare Diagnostics Business Overview Table 54. Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 56. Siemens Healthcare Diagnostics Recent Development Table 57. Sekisui Diagnostics Company Information Table 58. Sekisui Diagnostics Business Overview Table 59. Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 61. Sekisui Diagnostics Recent Development Table 62. Remel Company Information Table 63. Remel Business Overview Table 64. Remel Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Remel Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 66. Remel Recent Development Table 67. Quidel Corporation Company Information Table 68. Quidel Corporation Business Overview Table 69. Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 71. Quidel Corporation Recent Development Table 72. Oxoid Limited Company Information Table 73. Oxoid Limited Business Overview Table 74. Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 76. Oxoid Limited Recent Development Table 77. Orion Diagnostica Oy Company Information Table 78. Orion Diagnostica Oy Business Overview Table 79. Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 81. Orion Diagnostica Oy Recent Development Table 82. Orasure Technologies Company Information Table 83. Orasure Technologies Business Overview Table 84. Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 86. Orasure Technologies Recent Development Table 87. Meridian Biosciences Company Information Table 88. Meridian Biosciences Business Overview Table 89. Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 91. Meridian Biosciences Recent Development Table 92. MedMira Company Information Table 93. MedMira Business Overview Table 94. MedMira Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. MedMira Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 96. MedMira Recent Development Table 97. Gen-Probe Company Information Table 98. Gen-Probe Business Overview Table 99. Gen-Probe Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Gen-Probe Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 101. Gen-Probe Recent Development Table 102. Celsis International Company Information Table 103. Celsis International Business Overview Table 104. Celsis International Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Celsis International Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 106. Celsis International Recent Development Table 107. Cellabs Company Information Table 108. Cellabs Business Overview Table 109. Cellabs Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Cellabs Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 111. Cellabs Recent Development Table 112. Bio-Rad Laboratories Company Information Table 113. Bio-Rad Laboratories Business Overview Table 114. Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 116. Bio-Rad Laboratories Recent Development Table 117. BioMerieux SA Company Information Table 118. BioMerieux SA Business Overview Table 119. BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 121. BioMerieux SA Recent Development Table 122. Becton Dickinson and Company Company Information Table 123. Becton Dickinson and Company Business Overview Table 124. Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 126. Becton Dickinson and Company Recent Development Table 127. Abbott Laboratories Company Information Table 128. Abbott Laboratories Business Overview Table 129. Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio Table 131. Abbott Laboratories Recent Development Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Automated and Rapid Microbiological Tests Bussiness Product Image Figure 2. Global Automated and Rapid Microbiological Tests Bussiness Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032) & (US$ Million) Figure 4. Global Automated and Rapid Microbiological Tests Bussiness Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Automated Identification & Susceptibility Systems Image Figure 8. Automated Tuberculosis Systems Image Figure 9. Automated Blood Culture Systems Image Figure 10. Streptococcal Infection Rapid Tests Image Figure 11. GC/Chlamydia Rapid Tests Image Figure 12. Other Image Figure 13. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type (2021-2032) Figure 16. Clinical Image Figure 17. Non-Clinical Image Figure 18. Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application (2021-2032) Figure 21. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032) & (US$ Million) Figure 24. North America Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032) & (US$ Million) Figure 30. South America Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Automated Identification & Susceptibility Systems
  • Automated Tuberculosis Systems
  • Automated Blood Culture Systems
  • Streptococcal Infection Rapid Tests
  • GC/Chlamydia Rapid Tests
  • Other
Applications
  • Clinical
  • Non-Clinical
Companies covered
  • Thermo Fisher Scientific
  • Roche
  • Siemens Healthcare Diagnostics
  • Sekisui Diagnostics
  • Remel
  • Quidel Corporation
  • Oxoid Limited
  • Orion Diagnostica Oy
  • Orasure Technologies
  • Meridian Biosciences
  • MedMira
  • Gen-Probe
  • Celsis International
  • Cellabs
  • Bio-Rad Laboratories
  • BioMerieux SA
  • Becton Dickinson and Company
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Automated and Rapid Microbiological Tests Bussiness Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Automated and Rapid Microbiological Tests Bussiness Market Dynamics
  1. 2.1 Automated and Rapid Microbiological Tests Bussiness Industry Trends
  2. 2.2 Automated and Rapid Microbiological Tests Bussiness Industry Drivers
  3. 2.3 Automated and Rapid Microbiological Tests Bussiness Industry Opportunities and Challenges
  4. 2.4 Automated and Rapid Microbiological Tests Bussiness Industry Restraints
3 Automated and Rapid Microbiological Tests Bussiness Market by Company
  1. 3.1 Global Automated and Rapid Microbiological Tests Bussiness Company Revenue Ranking in 2025
  2. 3.2 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Company (2021-2026)
  3. 3.3 Global Automated and Rapid Microbiological Tests Bussiness Company Ranking (2024-2026)
  4. 3.4 Global Automated and Rapid Microbiological Tests Bussiness Company Manufacturing Base and Headquarters
  5. 3.5 Global Automated and Rapid Microbiological Tests Bussiness Company Product Type and Application
  6. 3.6 Global Automated and Rapid Microbiological Tests Bussiness Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Automated and Rapid Microbiological Tests Bussiness Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Automated and Rapid Microbiological Tests Bussiness Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Automated and Rapid Microbiological Tests Bussiness Market by Type
  1. 4.1 Automated and Rapid Microbiological Tests Bussiness Type Introduction
  2. 4.1.1 Automated Identification & Susceptibility Systems
  3. 4.1.2 Automated Tuberculosis Systems
  4. 4.1.3 Automated Blood Culture Systems
  5. 4.1.4 Streptococcal Infection Rapid Tests
  6. 4.1.5 GC/Chlamydia Rapid Tests
  7. 4.1.6 Other
  8. 4.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type
  9. 4.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type (2021-2032)
  11. 4.2.3 Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type (2021-2032)
5 Automated and Rapid Microbiological Tests Bussiness Market by Application
  1. 5.1 Automated and Rapid Microbiological Tests Bussiness Application Introduction
  2. 5.1.1 Clinical
  3. 5.1.2 Non-Clinical
  4. 5.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application
  5. 5.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application (2021-2032)
  7. 5.2.3 Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application (2021-2032)
6 Automated and Rapid Microbiological Tests Bussiness Regional Value Analysis
  1. 6.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region (2021-2032)
  3. 6.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region: 2021-2026
  4. 6.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
  7. 6.3.2 North America Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
  10. 6.4.2 Europe Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
  16. 6.6.2 South America Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
7 Automated and Rapid Microbiological Tests Bussiness Country-level Value Analysis
  1. 7.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2021-2032)
  3. 7.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2021-2026)
  4. 7.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Siemens Healthcare Diagnostics
  14. 8.3.1 Siemens Healthcare Diagnostics Company Information
  15. 8.3.2 Siemens Healthcare Diagnostics Business Overview
  16. 8.3.3 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  18. 8.3.5 Siemens Healthcare Diagnostics Recent Developments
  19. 8.4 Sekisui Diagnostics
  20. 8.4.1 Sekisui Diagnostics Company Information
  21. 8.4.2 Sekisui Diagnostics Business Overview
  22. 8.4.3 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  24. 8.4.5 Sekisui Diagnostics Recent Developments
  25. 8.5 Remel
  26. 8.5.1 Remel Company Information
  27. 8.5.2 Remel Business Overview
  28. 8.5.3 Remel Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Remel Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  30. 8.5.5 Remel Recent Developments
  31. 8.6 Quidel Corporation
  32. 8.6.1 Quidel Corporation Company Information
  33. 8.6.2 Quidel Corporation Business Overview
  34. 8.6.3 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  36. 8.6.5 Quidel Corporation Recent Developments
  37. 8.7 Oxoid Limited
  38. 8.7.1 Oxoid Limited Company Information
  39. 8.7.2 Oxoid Limited Business Overview
  40. 8.7.3 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  42. 8.7.5 Oxoid Limited Recent Developments
  43. 8.8 Orion Diagnostica Oy
  44. 8.8.1 Orion Diagnostica Oy Company Information
  45. 8.8.2 Orion Diagnostica Oy Business Overview
  46. 8.8.3 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  48. 8.8.5 Orion Diagnostica Oy Recent Developments
  49. 8.9 Orasure Technologies
  50. 8.9.1 Orasure Technologies Company Information
  51. 8.9.2 Orasure Technologies Business Overview
  52. 8.9.3 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  54. 8.9.5 Orasure Technologies Recent Developments
  55. 8.10 Meridian Biosciences
  56. 8.10.1 Meridian Biosciences Company Information
  57. 8.10.2 Meridian Biosciences Business Overview
  58. 8.10.3 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  60. 8.10.5 Meridian Biosciences Recent Developments
  61. 8.11 MedMira
  62. 8.11.1 MedMira Company Information
  63. 8.11.2 MedMira Business Overview
  64. 8.11.3 MedMira Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MedMira Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  66. 8.11.5 MedMira Recent Developments
  67. 8.12 Gen-Probe
  68. 8.12.1 Gen-Probe Company Information
  69. 8.12.2 Gen-Probe Business Overview
  70. 8.12.3 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  72. 8.12.5 Gen-Probe Recent Developments
  73. 8.13 Celsis International
  74. 8.13.1 Celsis International Company Information
  75. 8.13.2 Celsis International Business Overview
  76. 8.13.3 Celsis International Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Celsis International Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  78. 8.13.5 Celsis International Recent Developments
  79. 8.14 Cellabs
  80. 8.14.1 Cellabs Company Information
  81. 8.14.2 Cellabs Business Overview
  82. 8.14.3 Cellabs Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cellabs Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  84. 8.14.5 Cellabs Recent Developments
  85. 8.15 Bio-Rad Laboratories
  86. 8.15.1 Bio-Rad Laboratories Company Information
  87. 8.15.2 Bio-Rad Laboratories Business Overview
  88. 8.15.3 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  90. 8.15.5 Bio-Rad Laboratories Recent Developments
  91. 8.16 BioMerieux SA
  92. 8.16.1 BioMerieux SA Company Information
  93. 8.16.2 BioMerieux SA Business Overview
  94. 8.16.3 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  96. 8.16.5 BioMerieux SA Recent Developments
  97. 8.17 Becton Dickinson and Company
  98. 8.17.1 Becton Dickinson and Company Company Information
  99. 8.17.2 Becton Dickinson and Company Business Overview
  100. 8.17.3 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  102. 8.17.5 Becton Dickinson and Company Recent Developments
  103. 8.18 Abbott Laboratories
  104. 8.18.1 Abbott Laboratories Company Information
  105. 8.18.2 Abbott Laboratories Business Overview
  106. 8.18.3 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
  108. 8.18.5 Abbott Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research